Medicine · Hematological Malignancies (Leukemias, Lymphoma, Myeloma, Myeloproliferative)

A 58-year-old man with newly diagnosed multiple myeloma has serum beta-2 microglobulin of 5.8 mg/L and serum albumin of 3.2 g/dL. FISH analysis shows del(13q) as the sole abnormality. According to the Revised International Staging System (R-ISS), what stage is he classified as?

  • A R-ISS Stage II or III depending on LDH level
  • B R-ISS Stage II
  • C R-ISS Stage III
  • D R-ISS Stage I
Correct answer: A. R-ISS Stage II or III depending on LDH level

Explanation

R-ISS Stage III requires beta-2 microglobulin ≥5.5 mg/L PLUS either high-risk cytogenetics (del(17p), t(4;14), or t(14;16)) OR elevated LDH. This patient has beta-2 microglobulin 5.8 mg/L (ISS III threshold met) and del(13q) alone, which is not high-risk by R-ISS criteria. Without high-risk cytogenetics, he needs elevated LDH to be Stage III; otherwise he is R-ISS Stage II. Del(13q) alone does not confer high-risk status in R-ISS.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphoma, Myeloma, Myeloproliferative) MCQs

See all Hematological Malignancies (Leukemias, Lymphoma, Myeloma, Myeloproliferative) MCQs →